Pulmonary hypertension
H Olschewski, A Ghofrani, R Wiedemann… - Internist …, 2002 - Wiley Online Library
According to a study in 61 patients with primary pulmonary hypertension and collagen
vascular disease-associated pulmonary hypertension, being treated in a centre for …
vascular disease-associated pulmonary hypertension, being treated in a centre for …
Le sildenafil (Viagra®), 5 ans après: données actuelles en pathologie cardiovasculaire
N Danchin - Annales de Cardiologie et d'Angéiologie, 2002 - Elsevier
Résumé Le sildenafil (Viagra®), inhibiteur de la phosphodiesterase 5, a une action
vasodilatatrice puissante au niveau des corps caverneux, qui en a fait un médicament de …
vasodilatatrice puissante au niveau des corps caverneux, qui en a fait un médicament de …
Opinion and Evidence in Respiratory Medicine
Adis Editorial - 2002 - Springer
Respiratory Medicine is a vast and evolving area for researchers, primary care physicians
and specialists. To help keep you up-to-date with the latest advances worldwide on all …
and specialists. To help keep you up-to-date with the latest advances worldwide on all …
[PDF][PDF] 특발성폐섬유증(IPF) 의치료
김동순 - 대한결핵및호흡기학회워크샵, 2002 - researchgate.net
특발성폐섬유증 (IPF) 은 원인 모르게 폐 내에 섬유화가 진행하여 대개 진단 후 3 년 내에 반수가
사망한다고 알려진 치명적인 질환이나 효과적인 치료법을 아직은 찾지 못하고 있다 1-5. IPF 는 …
사망한다고 알려진 치명적인 질환이나 효과적인 치료법을 아직은 찾지 못하고 있다 1-5. IPF 는 …